Citation Impact
Citing Papers
Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
2014
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Breast Cancer Metastasis to the Central Nervous System
2005
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
2008
Comparative methodological analysis of erbB‐2/HER‐2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic use
2000
Dissecting the Heterogeneity of Triple-Negative Breast Cancer
2012
Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma
2003 StandoutNobel
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
2012
Triple-Negative Breast Cancer
2010 Standout
Primary breast cancer phenotypes associated with propensity for central nervous system metastases
2006
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
2009 Standout
High resolution stationary digital breast tomosynthesis using distributed carbon nanotube x‐ray source array
2012
The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours
1997
Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor
2014 StandoutNobel
Genes that mediate breast cancer metastasis to the brain
2009 StandoutNature
Breast Cancers With Brain Metastases are More Likely to be Estrogen Receptor Negative, Express the Basal Cytokeratin CK5/6, and Overexpress HER2 or EGFR
2006
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
2012
Ovarian cancer
2014 Standout
Wnt signaling in cancer
2016 Standout
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
The benefits and harms of breast cancer screening: an independent review
2013
A compendium of proteins that interact with HIF-1α
2017 StandoutNobel
Expression of Dicer and Drosha in triple-negative breast cancer
2012
Live-cell phenotypic-biomarker microfluidic assay for the risk stratification of cancer patients via machine learning
2018
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
2017 Standout
Molecular mechanisms of cisplatin resistance
2011 Standout
Helping women make choices about mammography screening: An online randomized trial of a decision aid for 40-year-old women
2010
Screening Mammography for Women 40 to 49 Years of Age: A Clinical Practice Guideline from the American College of Physicians
2007
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
High-performance medicine: the convergence of human and artificial intelligence
2018 Standout
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
2010
Reading the prognosis of the individual with breast cancer
2007
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
2007
MicroRNA biogenesis pathways in cancer
2015 Standout
Expression of the Hypoxia-Inducible and Tumor-Associated Carbonic Anhydrases in Ductal Carcinoma in Situ of the Breast
2001 StandoutNobel
Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
2005
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
2017 Standout
Differentiation Generates Paracrine Cell Pairs That Maintain Basaloid Mouse Mammary Tumors: Proof of Concept
2011
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Autism
2013 Standout
Capturing complex 3D tissue physiology in vitro
2006 Standout
Saturation in qualitative research: exploring its conceptualization and operationalization
2017 Standout
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial
2010
The molecular landscape of head and neck cancer
2018 Standout
Therapeutic potential of PARP inhibitors for metastatic breast cancer
2011
Breast Cancer Screening With Imaging: Recommendations From the Society of Breast Imaging and the ACR on the Use of Mammography, Breast MRI, Breast Ultrasound, and Other Technologies for the Detection of Clinically Occult Breast Cancer
2010
Loss of Dicer expression is associated with breast cancer progression and recurrence
2012
Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy
2010
Effectiveness of population‐based service screening with mammography for women ages 40 to 49 years
2010
A novel method for prediction of long-term outcome of women with T1a, T1b, and 10–14 mm invasive breast cancers: a prospective study
2000
Current status of full-field digital mammography
2000
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
2005 Standout
Pattern of metastatic spread in triple-negative breast cancer
2008
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
The shifting nature of women’s experiences and perceptions of ductal carcinomain situ
2011
Early Autism Detection: Are We Ready for Routine Screening?
2011
Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation
2016
Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography
2003 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
2016 Standout
Direct Serum Assay for MicroRNA-21 Concentrations in Early and Advanced Breast Cancer
2010
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Increased Incidence of Visceral Metastases in Scottish Patients With BRCA1/2-Defective Ovarian Cancer: An Extension of the Ovarian BRCAness Phenotype
2010
Decision aids for people facing health treatment or screening decisions
2017 Standout
Breast Cancer Treatment
2019 Standout
The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study
2018
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation
2016
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
2016
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Cancer Genome Landscapes
2013 StandoutScience
The role of hypoxia‐inducible factors in carotid body (patho) physiology
2018 StandoutNobel
Screening for breast cancer with mammography
2013
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Encapsulation of Au/Fe3O4 nanoparticles into a polymer nanoarchitecture with combined near infrared-triggered chemo-photothermal therapy based on intracellular secondary protein understanding
2017
Regulation of cell proliferation by hypoxia-inducible factors
2015 StandoutNobel
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Works of Andy Evans being referenced
Randomised controlled trial of mammographic screening in women from age 40: results of screening in the first 10 years
2005
Correlations between the mammographic features of ductal carcinoma In situ (DCIS) and C-erbB-2 oncogene expression
1994
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
2009
Patterns of metastatic breast carcinoma: influence of tumour histological grade
2004
The Influence of Basal Phenotype on the Metastatic Pattern of Breast Cancer
2007
Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.
1994
Radiological findings of screen-detected cancers in a multi-centre randomized, controlled trial of mammographic screening in women from age 40 to 48 years
2006
Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial
2006
Brain metastases from breast cancer: identification of a high-risk group
2004
The effect of mammography pain on repeat participation in breast cancer screening: A systematic review
2013
Overdiagnosis in breast imaging
2016
The effect of hormone replacement therapy on recall rate in the national health service breast screening programme
1997
The positive predictive value of mammographic signs: A review of 425 non-palpable breast lesions
1996
The prognoses of tumours detected in the UK breast screening programme (NHS BSP) analysed by the Nottingham Prognostic Index (NPI)
2004
Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease?
2001